NCT07490717

Developing and Testing Innovative Care Pathways for Screening and Treatment of OUD/PTSD in Jails

Enrolling by Invitation
NAAges 18+InterventionalTreatment
University of Arkansas
~338 participants
Updated 2026-06-18 on ClinicalTrials.gov
What's tested:Cognitive Processing Therapy (CPT)Written Exposure Therapy (WET)

At a glance

Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
A2 - Substance Use Treatment Initiation
Measured over Through study completion, approximately 1 year
Post-traumatic Stress Disorder (PTSD)
Post-traumatic Stress Symptoms
Opioid Use Disorder (OUD)
Stimulant Use Disorder
Stimulant Use & Co-occuring Opioid Use Disorders
Co-occurring Mental and Substance Use Disorders
Medications for Opioid Use Disorder
2 sites across 1 states
Arkansas2

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18 years of age or older
Able to understand and speak English
Able to give informed consent
Invited by the PI to participate, due to specific role within the project site
Incarcerated at the study site
Screened positive for probable PTSD and OUD/STUD as part of the SBIRT-J process
Have an expected duration of incarceration that is compatible with receiving trauma-focused treatment and completing assessments within the remaining timeline of the study

Exclusion

Unwilling to consent to randomization
Unable to provide locator information for post-release assessments
Currently experiencing psychiatric symptoms that would preclude participation in CPT or WET (e.g., severe behavioral dysregulation, severe psychotic symptoms)
  • A2 - Substance Use Treatment InitiationThrough study completion, approximately 1 year

    Substance use treatment initiation (binary; presence vs absence) will be assessed via participant self-report and verified via medical chart review when possible.